Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Giralt

Showing results (21-30 of 340) with videos related to

Pageof 34
Sort By:
Hematology/Oncology Clinics of North America|September 13, 2014
Treatment of transplant-eligible patients with multiple myeloma in 2014Heather Landau, Sergio Giralt
Blood|March 29, 2020
Compliments to complement blockade for TA-TMAMichael Scordo, Sergio Giralt
Current Hematologic Malignancy Reports|October 23, 2013
Allogeneic hematopoietic stem cell transplantation for multiple myeloma: what place, if any?Sergio Giralt, Guenther Koehne
Current Hematology Reports|June 26, 2004
Stem cell transplantation for multiple myeloma: current status and future directionsHumberto Caldera, Sergio Giralt
Hematology. American Society of Hematology. Education Program|December 4, 2018
Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patientsSergio Giralt, Eric Seifter
Current Opinion in Oncology|September 11, 2012
Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of careGuenther Koehne, Sergio Giralt
Cancer Treatment and Research|September 26, 2009
Principles and overview of allogeneic hematopoietic stem cell transplantationSergio Giralt, Michael R Bishop
Seminars in Hematology|April 18, 2006
Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndromeMarcos de Lima, Sergio Giralt
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Therapy for older AML patients: the role of novel agents and allogeneic stem cell transplantJeffrey E Lancet, Sergio Giralt
Expert Review of Hematology|February 5, 2013
Assessing response of therapy for acute and chronic graft-versus-host diseaseJenna D Goldberg, Sergio Giralt
Pageof 34

Showing results (21-30 of 340) with videos related to

Sort By:
Pageof 34
Hematology/Oncology Clinics of North America|September 13, 2014
Treatment of transplant-eligible patients with multiple myeloma in 2014Heather Landau, Sergio Giralt
Blood|March 29, 2020
Compliments to complement blockade for TA-TMAMichael Scordo, Sergio Giralt
Current Hematologic Malignancy Reports|October 23, 2013
Allogeneic hematopoietic stem cell transplantation for multiple myeloma: what place, if any?Sergio Giralt, Guenther Koehne
Current Hematology Reports|June 26, 2004
Stem cell transplantation for multiple myeloma: current status and future directionsHumberto Caldera, Sergio Giralt
Hematology. American Society of Hematology. Education Program|December 4, 2018
Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patientsSergio Giralt, Eric Seifter
Current Opinion in Oncology|September 11, 2012
Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of careGuenther Koehne, Sergio Giralt
Cancer Treatment and Research|September 26, 2009
Principles and overview of allogeneic hematopoietic stem cell transplantationSergio Giralt, Michael R Bishop
Seminars in Hematology|April 18, 2006
Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndromeMarcos de Lima, Sergio Giralt
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Therapy for older AML patients: the role of novel agents and allogeneic stem cell transplantJeffrey E Lancet, Sergio Giralt
Expert Review of Hematology|February 5, 2013
Assessing response of therapy for acute and chronic graft-versus-host diseaseJenna D Goldberg, Sergio Giralt
Pageof 34